Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2026-04-19 @ 11:09 PM
Study NCT ID:
NCT01296256
Status:
COMPLETED
Last Update Posted:
2016-02-17
First Post:
2011-02-13
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Bendamustine, Cytarabine, Etoposide and Melphalan (BeEAM) as Conditioning for Autologous Stem Cell Transplant (ASCT) in Aggressive Non Hodgkin's Lymphoma (NHL).
Sponsor:
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
Benda-EAM2010-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None